Bovalto Ibraxion

RSS

Withdrawn

This medicine's authorisation has been withdrawn

infectious bovine rhinotracheitis vaccine (inactivated)
MedicineVeterinaryWithdrawn

Estonian is available via eTranslation, the European Commission's machine translation service.

Translate to Estonian | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Bovalto Ibraxion has been withdrawn at the request of the marketing authorisation holder.

български (BG) (273.86 KB - PDF)

Vaata

español (ES) (211.53 KB - PDF)

Vaata

čeština (CS) (261.66 KB - PDF)

Vaata

dansk (DA) (213.32 KB - PDF)

Vaata

Deutsch (DE) (220.08 KB - PDF)

Vaata

eesti (ET) (204.87 KB - PDF)

Vaata

ελληνικά (EL) (286.33 KB - PDF)

Vaata

français (FR) (212.65 KB - PDF)

Vaata

hrvatski (HR) (231.45 KB - PDF)

Vaata

italiano (IT) (209.38 KB - PDF)

Vaata

latviešu (LV) (244.51 KB - PDF)

Vaata

lietuvių (LT) (233 KB - PDF)

Vaata

magyar (HU) (249.94 KB - PDF)

Vaata

Malti (MT) (258.21 KB - PDF)

Vaata

Nederlands (NL) (211.02 KB - PDF)

Vaata

polski (PL) (256.51 KB - PDF)

Vaata

português (PT) (211.11 KB - PDF)

Vaata

română (RO) (235.21 KB - PDF)

Vaata

slovenčina (SK) (258.12 KB - PDF)

Vaata

slovenščina (SL) (244.33 KB - PDF)

Vaata

suomi (FI) (209.31 KB - PDF)

Vaata

svenska (SV) (209.74 KB - PDF)

Vaata

Product information

български (BG) (705.71 KB - PDF)

Vaata

español (ES) (674.36 KB - PDF)

Vaata

čeština (CS) (969.79 KB - PDF)

Vaata

dansk (DA) (624.29 KB - PDF)

Vaata

Deutsch (DE) (661.81 KB - PDF)

Vaata

eesti (ET) (692.55 KB - PDF)

Vaata

ελληνικά (EL) (1.19 MB - PDF)

Vaata

français (FR) (671.79 KB - PDF)

Vaata

hrvatski (HR) (767.57 KB - PDF)

Vaata

italiano (IT) (679.81 KB - PDF)

Vaata

latviešu (LV) (999.57 KB - PDF)

Vaata

lietuvių (LT) (791.74 KB - PDF)

Vaata

magyar (HU) (981.94 KB - PDF)

Vaata

Malti (MT) (1007.77 KB - PDF)

Vaata

Nederlands (NL) (671.31 KB - PDF)

Vaata

polski (PL) (993.05 KB - PDF)

Vaata

português (PT) (664.06 KB - PDF)

Vaata

română (RO) (792.26 KB - PDF)

Vaata

slovenčina (SK) (995.67 KB - PDF)

Vaata

slovenščina (SL) (960.57 KB - PDF)

Vaata

suomi (FI) (678.92 KB - PDF)

Vaata

svenska (SV) (676.34 KB - PDF)

Vaata

Íslenska (IS) (680.52 KB - PDF)

Vaata

norsk (NO) (684.14 KB - PDF)

Vaata
Latest procedure affecting product information:IAIN/0016
10/08/2016

български (BG) (333.69 KB - PDF)

Vaata

español (ES) (172.7 KB - PDF)

Vaata

čeština (CS) (205.62 KB - PDF)

Vaata

dansk (DA) (172.68 KB - PDF)

Vaata

Deutsch (DE) (173.21 KB - PDF)

Vaata

eesti (ET) (168.31 KB - PDF)

Vaata

ελληνικά (EL) (215.76 KB - PDF)

Vaata

français (FR) (171.23 KB - PDF)

Vaata

hrvatski (HR) (192.67 KB - PDF)

Vaata

italiano (IT) (168.65 KB - PDF)

Vaata

latviešu (LV) (209.34 KB - PDF)

Vaata

lietuvių (LT) (200.78 KB - PDF)

Vaata

magyar (HU) (191.94 KB - PDF)

Vaata

Malti (MT) (214.75 KB - PDF)

Vaata

Nederlands (NL) (170.59 KB - PDF)

Vaata

polski (PL) (207.14 KB - PDF)

Vaata

português (PT) (172.47 KB - PDF)

Vaata

română (RO) (195.44 KB - PDF)

Vaata

slovenčina (SK) (209.19 KB - PDF)

Vaata

slovenščina (SL) (240.02 KB - PDF)

Vaata

suomi (FI) (166.83 KB - PDF)

Vaata

svenska (SV) (172.67 KB - PDF)

Vaata

Íslenska (IS) (170.24 KB - PDF)

Vaata

norsk (NO) (168.61 KB - PDF)

Vaata

Product details

Name of medicine
Bovalto Ibraxion
Active substance
inactivated IBR virus
International non-proprietary name (INN) or common name
infectious bovine rhinotracheitis vaccine (inactivated)
Species
Cattle
Anatomical therapeutic chemical veterinary (ATCvet) code
QI02AA03

Pharmacotherapeutic group

Immunologicals for Bovidae

Therapeutic indication

Active immunisation of cattle to reduce the clinical signs of infectious bovine rhinotracheitis (IBR) and field virus excretion.
The onset of immunity is 14 days and the duration of immunity is 6 months.

Authorisation details

EMA product number
EMEA/V/C/000051
Marketing authorisation holder
Merial

29 Avenue Tony Garnier
69007 Lyon
France

Marketing authorisation issued
09/03/2000
Revision
10

Assessment history

This page was last updated on

Share this page